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Staphylococcal bi-component toxins, leukocldin and y-hemolysm, consist of two protein components, i.e. F and S for leukocidin and HyI and HyII 
for y-hemolysin. In this study we purified HyI and HyII to homogeneity from the culture medmm of Stuphl,lococcus aureus RIMD 310925 and 
compared their properties with those of F and S purified from the same source. The N-terminal 59- and C-terminal 2-residue ammo acid sequences, 
apparent molecular mass, and isoelectric point of purified HyI were the same as those of F. In an Ouchterlony double diffusion test a fused line 
without spur was formed between F and HyI using either anti-F or anti-HyI antlbodies A synergistic action of F and HyII caused hemolysis of 
human red blood cells, and HyI acted synergistlcally with S to exhibit leukocldin activity We conclude that the two toxins share one protein 
component (F = HyI) in common and leukoadin- and y-hemolysin-specific activities are determined by S and HyII, respectively. It IS also reported 
that the N-terminal S&residue sequence of HyII is 72% similar to the corresponding sequence of S. 
Leukocldin; y-Hemolysin: Staphylococcus aureus 
1. INTRODUCTION 
Leukocidin and y-hemolysin are two toxins secreted 
by Staphylococcus aureus and cause cytotoxic changes 
in polymorphonuclear leukocytes and hemolysis in red 
blood cells, respectively [1,2]. Both toxin activities are 
known to result from a synergistic action of the two 
protein components, i.e. F and S for leukocidin and HyI 
and HyII for y-hemolysin [1,2]. The two toxins have 
sofar been studied as distinct entities having no struc- 
tural or functional similarities. However, bi-component 
specificity of the two toxins raises the question whether 
or not there is any relationship between them. To an- 
swer this question, it is necessary to obtain homogene- 
ous preparations of the two components of y-hemoly- 
sin. In this study we purified both HyI and HyII com- 
ponents to homogeneity from the culture medium of S. 
aureus and compared their properties with those of F 
and S components of leukocidin. Here we report evi- 
dence that leukocidin F is identical with y-hemolysin 
HyI. 
2. MATERIALS AND METHODS 
2.1. PuriJication of Hyl and HyII components 
Methicilhn-resistant S. aureus strain No. 4 (RIMD 310925), which 
was used m previous studies [3,4] was grown m 2.5% heart infusion 
broth (Dlfco) at 37°C for 24 h with vigorous aeration. and then the 
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culture medium was harvested by centrifugatlon at4’C. HyI and HyII 
were partially purified from the culture medium by hydroxylapatite 
column chromatography as described by Plommet [2], and then fur- 
ther purified by HPLC (TOSOH, Tokyo) equipped with a TSK gel 
SP-5PW column (TOSOH. Tokyo). HyI and HyII were thereby eluted 
from the column with a linear gradient of NaCl in 10 mM potassium 
phosphate buffer (pH 6.8) (Buffer A) at about 0.15 M and about 0.8 
M NaCl, respectively. HyI- and HyII-contaimng fractions were sepa- 
rately pooled, dialyzed against Buffer A and stored at -80°C. 
2 2. Assay of leukocidrn and y-hemolysm activities 
Leukocidm and y-hemolysin activities were determined by the 
methods of Noda et al. [5] and of Plommet [2]. respectively. 
2.3. SDS-PAGE and Western lmmunoblot unal~sls 
SDS-PAGE and Western immunoblot analysis were done by the 
methods described previously [6]. Polyclonal antibodies were raised 
against leukocldin F and S components purified from S. aureus V8 as 
described earher [4]. 
2.4. Preparation of antisera ugarnst pur$ed Hyl und HyII 
Rabbit antisera against y-hemolysin Hyl and HyII were prepared 
by the method described previously 161. 
2.5. Determination of N- and C-terminal amino acid sequences 
The N-terminal sequence was determined by automated Edman 
degradation usmg a gas phase protein sequencer (model 473A, ABI 
Co.) equipped with an on-line PTH amino acid analyzer (model 120A, 
ABI Co.) and C-terminal sequence was determined by carboxypeptl- 
dase Y digestion as described by Hayashi et al. [7]. The ammo acids 
released from the C-terminus were dabsylated by the method of Stoc- 
chi et al. [8] and analyzed by an ammo acid analyzer (Beckman, System 
Gold). 
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tively. The cloned S and F preparations were purified with HPLC 
equipped with TSK gel SP-SPW column. The F and S were eluted from 
the column with a linear gradient of NaCl in Buffer A at about 0.15 
M and about 0.65 M, respectively. The cloned F and S thus obtamed 
were found to be homogeneous by SDS-PAGE (data not shown). 
3. RESULTS AND DISCUSSION 
3.1. Pur~jication of y-hemolqtsin components 
Purification of the two components HyI and HyII of 
y-hemolysin, from 20 liter culture fluid to the degree of 
electrophoretic homogeneity yielded 5 mg and 60 mg 
protein, respectively (Fig. 1). The S. areas strain used 
seemed to secrete a larger amount of HyII than HyI. 
The molecular mass of purified HyI (34 kDa) was the 
same as that of leukocidin F component [4]. When co- 
chromatographed, HyI and F were inseparable on both 
TX gel HA-1000 (TOSOH, Tokyo) and SP-5PW col- 
umns in HPLC (data not shown). HyII showed a some- 
what smaller molecular mass (32 kDa) than leukocidin 
S (33 kDa) [3] on SDS-PAGE (Fig. 1). The isoelectric 
points of HyI and HyII were determined by the method 
described previously [6] to be 9.1 and 9.4, respectively. 
The value for HyI coincided with that for the leukocidin 
F component [4]. 
3.2. Amino ucid composition und N- and C-terminul 
amino ncid sequences of Hyl and HyII 
As shown in Table I, the amino acid composition of 
HyI was almost the same as that of leukocidin F calcu- 
lated from its predicted primary structure [4]. The C- 
terminal amino acid sequences of HyI and HyII were 
determined to be -Asn-Lys-OH and -Ser-Ile-Thr-Pro- 
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Fig. 1. SDS-PAGE of F, S, HyI and HyII. The gel was stained with 
Coomassie brilliant blue R-250. Molecular weight standards used 
were phosphorylase b (97.4 kDa), bovine serum albumin (66.2 kDa). 
ovalbumm (45 kDa), bovine carbonic anhydrase (31 kDa) and soy- 
bean trypsin inhibitor (21.5 kDa). Lanes MW, molecular weight 
standards: 1, S; 2. HyII; 3. F; 4, HyI. 
Lys-OH, respectively. The C-terminal 2-residue and N- 
terminal 59-residue sequences of HyI were identical 
with those predicted for F (Table II). On the other hand, 
the N-terminal 58-residue sequence of HyII determined 
in this study was 72% identical with the corresponding 
sequences of leukocidin S (Table II), but no homology 
was found between the C-terminal 5-residue sequences 
of HyII and S. 
3.3. Immunoblotting unul~sis and Ouchterlon~~ double 
u’jjksion test of y-hemollasin HyI and HyII 
In view of the similarity of the N-terminal amino acid 
sequences of y-hemolysin HyI and HyII to those of 
leukocidin F and S, respectively, we performed a com- 
parative immunological study between the components 
of both toxins. Hyl and HyII were positive to anti-F 
and anti-S antibodies, respectively, whereas they did not 
cross-react to anti-S and anti-F antibodies, respectively 
(Fig. 2A and B). 
Table 1 
Amino acid compostttons of HyI and HyII components of y-hemoly- 
sin, and S and F components of leukocidm of S. uureus 
Ammo acid No. of ammo acid residues 
HYI F HyII S 
component” componentb component” componentb 
LYS 
Arg 
His 
Asp 
Asn i 
Glu 
Gln 
Thr 
Ser 
Gly 
Ala 
Val 
Ile 
Leu 
CYs 
Trp 
Met 
Tyr 
Phe 
Pro 
28 
9 
5 
47 
26 
22 22 
27 26 
22 21 
15 17 
16 15 
14 14 
18 18 
0 0 
6 6 
3 3 
18 18 
15 16 
8 8 
28 
10 
5 
17 
46 
29 
30 2-I 
11 8 
4 8 
16 
39 42 
26 
13 
25 26 
13 
18 20 
23 30 
17 20 
14 10 
18 19 
21 16 
12 12 
0 0 
3 4 
3 3 
17 18 
13 14 
12 9 
Total residue 299 298 280 286 
Calculated Mr 33,946 33.917 31,921 32.528 
*Determined by amino acid analysis of purified HyI and HyII compo- 
nents from S artreus RIMD 310925. 
bCalculated from the predicted amino acid sequence of F and S com- 
ponents [3.4]. 
Cysteme was determined after performic oxidation and hydrolysis of 
the preparation for 24 h by the method of Moore [9]. Determination 
of tryptophan levels was carried out in 6 M guanidme hydrochloride 
by the method of Bencze and Schmid [lo]. 
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Table 11 
Comparison of N-termmal ammo acids sequence of F, S. HyI and HyII components from S. aureu~ 
Protein Residue Sequencea 
I? l-29 EGKITPVSVKKVDDKVTLYKTTATADSDK 
HYI l-29 EGKITPVSVKKVDDKVTLYKTTATADSDK 
F 30-59 FKISQILTFNFIKDKSYDKDTLVLKATGNI 
WI 30-59 FKISQILTFNFIKDKSYDKDTLVLKATGNI 
S 
HyII 
S 
HyII 
* Identtcal residues at corresponding postttons m the compared sequence are boxed. 
In an Ouchterlony double diffusion test a fused line 
without spur was formed between F and HyI using 
either anti-F or anti-HyI antibodies (Fig. 2C and D), 
indicating that there is no apparent difference in anti- 
genie structure between them. S as well as HyII cross- 
reacted with anti-HyII serum (data not shown). 
6123 4 
D 
Fig. 2. Western blot (A and B) and Ouchterlony double diffusion test (C and D) of F, S, HyI and HyII preparations. using specific anti-serum 
against S (A) and F (B and C) or HyI (D). Lanes of both (A) and (B): 1, S: 2, HyII; 3. F; 4. HyI. For double diffusion test, the well, No. 1 of 
(C) and (D) contain antt-F and anti-HyI anttbodies, respectively. The wells, No. - 7 and No. 3 of both(C) and (D) contain 12,~g (10~1) F and HyI, 
respectively. In the case of (D). the specimen was stained with Coomassie brilhant blue R-250. 
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Fig. 3. y-Hemolysin synergism on human blood agarose plates, (A) and (B). The human blood agarose plate was prepared by the method of Plommet 
[2]. Plate A: 1, F + S; 2, HyI + HyII; 3. F + HyII; 4, HyI + S. Plate B: 1, cloned S; 2. cloned F; 3. HyI: 4. HyII. The concentration of each 
component was adjusted to 100 ng/pl in Buffer A. The amount ofeach component applied to the well was 3pg. The plates (A) and (B) were incubated 
at 37°C for 2 h and 18 h, respectively. 
3.4. Change from leukocidin activity to hemolysin activ- 
ity by substituting HyIIfor leukocidin S component 
The findings described above suggest that leukocidin 
F and y-hemolysin HyI components are identical. If F 
is a common factor for both leukocidin and y-hemoly- 
sin, and if the leukocidin- and y-hemolysin-specific ac- 
tivities are determined by S and HyII, leukocidin activ- 
ity should change to hemolytic activity by substituting 
HyII for S in combination with F. Accordingly, we 
examined the effect of S and HyII on the specificity of 
toxin activity in combination with leukocidin F compo- 
nent. A synergistic action of F and HyII caused hemo- 
lysis of human red blood cells (Fig. 3A). Cloned F also 
had hemolytic activity in combination with HyII (Fig. 
3B). HyI acted synergistically with S to exhibit leu- 
kocidin activity without hemolytic activity (data not 
shown). From these findings, we conclude that the two 
toxins share one protein component (F = HyI) in com- 
mon and the leukocidin- and y-hemolysin-specific activ- 
ities are determined by S and HyII, respectively. We 
have reconfirmed the above conclusion by cloning and 
nucleotide sequencing of the y-hemolysin gene(s) (sub- 
mitted elsewhere). 
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